Skip to main content
Skip to recall details
Verified · CPSCClass II — Possible RiskBaby & Kids

MiramarLab, of Doral, Florida Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious I Recall 2025

MiramarLab, of Doral, FloridaIssued December 18, 2025

MiramarLab, of Doral, Florida Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging — recalled per CPSC on 12/18/2025. Reason: The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children..

Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
Issuing agency
CPSC
Issued
Dec 18, 2025
Brand
MiramarLab, of Doral, Florida
States affected
1

What to do right now

  1. 1

    Stop using it

    Take it out of rotation. Don't consume, wear, or operate.

  2. 2

    Verify the match

    Compare lot numbers, UPCs, and dates against your product.

  3. 3

    Return or dispose

    Follow the manufacturer's instructions to refund or safely dispose.

Verified source

U.S. Consumer Product Safety Commission

Summary of the official CPSC notice issued December 18, 2025. Last synced Apr 27, 2026. View on cpsc.gov

What's recalled

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Why it was recalled

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

Where was it sold
1 state
nationwide
View official CPSC notice

View all questions for this recall →

More recalls like this
4 related — by brand, contaminant, and category

Frequently asked questions

Is the MiramarLab, of Doral, Florida recall still active?

Yes, this recall is currently active as of December 18, 2025. Do not use or consume the affected product.

How do I know if my MiramarLab, of Doral, Florida is affected?

All units of MiramarLab, of Doral, Florida matching the description above are affected.

What should I do if I have the recalled MiramarLab, of Doral, Florida?

Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.